-transparent.png){kind=logo}
Serum aldose reductase activity was estimated spectrophotometrically in 25 normal subjects (Group A), 25 diabetic patients without retinopathy (Group B), and 25 diabetic patients with retinopathy (Group C). Serum aldose reductase levels were higher in diabetic patients with or without retinopathy than in normal subjects. Comparing the serum aldose reductase activity in diabetic patients with and without retinopathy showed the value was higher in the former group; this difference was statistically significant (P < .01). However, aldose reductase activity in proliferative and background retinopathy were equal and therefore not significant.
Related Publications
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
March 2011,
Current pharmaceutical biotechnology,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
August 2010,
Diabetes care,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
November 1999,
Diabetes research and clinical practice,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
March 2003,
Ophthalmic genetics,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
March 2008,
Molecular vision,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
December 2002,
The British journal of ophthalmology,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
February 1994,
Diabetes,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
November 2016,
Diabetes research and clinical practice,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
January 1990,
The Journal of diabetic complications,
R Singh, and
D Dash, and
F J Ansari, and
O P Maurya, and
V P Singh
November 1989,
Investigative ophthalmology & visual science,
